First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers

Ready, Neal ; Hellmann, Matthew D ; Awad, Mark M ; Otterson, Gregory A ; Gutierrez, Martin ; Gainor, Justin F ; Borghaei, Hossein ; Jolivet, Jacques ; Horn, Leora ; Mates, Mihaela ; Brahmer, Julie ; Rabinowitz, Ian ; Reddy, Pavan S ; Chesney, Jason ; Orcutt, James ; Spigel, David R ; Reck, Martin ; O'Byrne, Kenneth John ; Paz-Ares, Luis ; Hu, Wenhua ; Zerba, Kim ; Li, Xuemei ; Lestini, Brian ; Geese, William J ; Szustakowski, Joseph D ; Green, George ; Chang, Han ; Ramalingam, Suresh S

Journal of clinical oncology, 2019-04, Vol.37 (12), p.992-1000 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível